Browse studies
Find your next paid study
52 recruiting studies matching your filters
Phase 2
A Randomized Double-Blind Placebo-Controlled Phase II Multi-Center Study of Inflammation Modification of Canakinumab to Prevent Leukemic Progression of Clonal Cytopenias of Unknown Significance (CCUS): IMPACT Study
This phase II trial tests how well canakinumab works to prevent progression to cancer in patients with clonal cytopenias of unknown significance (CCUS). CCUS i…
Clonal Cytopenia of Undetermined Significance
Estimated
~$10 – $7,500
Uma BorateNCT05641831
Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
This is a prospective observational study that was designed with the following two Specific Aims: 1. To determine whether the Immature Platelet Fraction perce…
Neonatal Thrombocytopenia
Estimated
~$10 – $750
Boston Children's HospitalNCT03848923
Phase 1
A Multi-Site Break Through Cancer Pilot Study Testing the Feasibility and Safety of Therapeutic Intervention for Patients With High-risk Clonal Cytopenia of Undetermined Significance (CCUS)
This research is being done to find out more about the potential risks and benefits of early treatment in participants with high risk Clonal Cytopenia of Unkno…
Clonal Cytopenia of Undetermined SignificanceCytopenia
Estimated
~$10 – $7,500
Lachelle D. Weeks, MD, PhDNCT06802146
Pharmacogenomics of Heparin-Induced Thrombocytopenia
The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to hep…
Heparin-induced Thrombocytopenia
Estimated
~$10 – $750
University of ArizonaNCT02717039